1 Market Overview

1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 5-HT3 Inhibitors

1.2.3 NK1 Inhibitors

1.2.4 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Acute CINV

1.3.3 Delayed CINV

1.3.4 Breakthrough CINV

1.3.5 Others

1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size & Forecast

1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Value (2016-2026))

1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume (2016-2026)

1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2026) & (US$/Unit)

1.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity Analysis

1.5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Total Production Capacity (2016-2026)

1.5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers

1.6.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints

1.6.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Trends Analysis

2 Manufacturers Profiles

2.1 Heron Therapeutics

2.1.1 Heron Therapeutics Details

2.1.2 Heron Therapeutics Major Business

2.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Merck

2.2.1 Merck Details

2.2.2 Merck Major Business

2.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Eisai

2.3.1 Eisai Details

2.3.2 Eisai Major Business

2.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Mundipharma

2.4.1 Mundipharma Details

2.4.2 Mundipharma Major Business

2.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Qilu Pharma

2.5.1 Qilu Pharma Details

2.5.2 Qilu Pharma Major Business

2.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Teva

2.6.1 Teva Details

2.6.2 Teva Major Business

2.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Novartis

2.7.1 Novartis Details

2.7.2 Novartis Major Business

2.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Roche

2.8.1 Roche Details

2.8.2 Roche Major Business

2.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Mylan

2.9.1 Mylan Details

2.9.2 Mylan Major Business

2.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Baxter

2.10.1 Baxter Details

2.10.2 Baxter Major Business

2.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 GSK

2.11.1 GSK Details

2.11.2 GSK Major Business

2.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Helsinn

2.12.1 Helsinn Details

2.12.2 Helsinn Major Business

2.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Southwest Pharma

2.13.1 Southwest Pharma Details

2.13.2 Southwest Pharma Major Business

2.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Haisco

2.14.1 Haisco Details

2.14.2 Haisco Major Business

2.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Sun Pharma

2.15.1 Sun Pharma Details

2.15.2 Sun Pharma Major Business

2.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

2.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturer

3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs

3.4 Market Concentration Rate

3.4.1 Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share

3.4.2 Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer Market Share

3.5 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region

4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Region (2016-2026)

4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2026)

4.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026)

4.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026)

4.4 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026)

4.5 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026)

4.6 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Type (2016-2026)

5.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2016-2026)

5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Application (2016-2026)

6.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2016-2026)

6.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2026)

7.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2026)

7.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country

7.3.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Country (2016-2026)

7.3.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2026)

8.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2026)

8.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country

8.3.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Country (2016-2026)

8.3.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2026)

9.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2026)

9.3 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region

9.3.1 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2026)

10.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2026)

10.3 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country

10.3.1 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Country (2016-2026)

10.3.2 South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2026)

11.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2026)

11.3 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Country

11.3.1 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Distributors

12.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type, (USD Million), 2021-2026

Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application, (USD Million), 2021-2026

Table 3. Heron Therapeutics Basic Information, Manufacturing Base and Competitors

Table 4. Heron Therapeutics Major Business

Table 5. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 6. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Merck Basic Information, Manufacturing Base and Competitors

Table 8. Merck Major Business

Table 9. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 10. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Eisai Basic Information, Manufacturing Base and Competitors

Table 12. Eisai Major Business

Table 13. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 14. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Mundipharma Basic Information, Manufacturing Base and Competitors

Table 16. Mundipharma Major Business

Table 17. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 18. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Qilu Pharma Basic Information, Manufacturing Base and Competitors

Table 20. Qilu Pharma Major Business

Table 21. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 22. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Teva Basic Information, Manufacturing Base and Competitors

Table 24. Teva Major Business

Table 25. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 26. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Novartis Basic Information, Manufacturing Base and Competitors

Table 28. Novartis Major Business

Table 29. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 30. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Roche Basic Information, Manufacturing Base and Competitors

Table 32. Roche Major Business

Table 33. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 34. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Mylan Basic Information, Manufacturing Base and Competitors

Table 36. Mylan Major Business

Table 37. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 38. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Baxter Basic Information, Manufacturing Base and Competitors

Table 40. Baxter Major Business

Table 41. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 42. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. GSK Basic Information, Manufacturing Base and Competitors

Table 44. GSK Major Business

Table 45. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 46. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Helsinn Basic Information, Manufacturing Base and Competitors

Table 48. Helsinn Major Business

Table 49. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 50. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Southwest Pharma Basic Information, Manufacturing Base and Competitors

Table 52. Southwest Pharma Major Business

Table 53. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 54. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Haisco Basic Information, Manufacturing Base and Competitors

Table 56. Haisco Major Business

Table 57. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 58. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Sun Pharma Basic Information, Manufacturing Base and Competitors

Table 60. Sun Pharma Major Business

Table 61. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product and Services

Table 62. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturer (2019-2021e) & (M Units)

Table 64. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 65. Market Position of Manufacturers in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 66. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity by Company, (M Units): 2020 VS 2021

Table 67. Head Office and Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Site of Key Manufacturer

Table 68. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs New Entrant and Capacity Expansion Plans

Table 69. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Mergers & Acquisitions in the Past Five Years

Table 70. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021e) & (M Units)

Table 71. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026) & (M Units)

Table 72. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021e) & (USD Million)

Table 73. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2021-2026) & (USD Million)

Table 74. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 75. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 76. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2016-2021e) & (USD Million)

Table 77. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2021-2026) & (USD Million)

Table 78. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2021e) & (US$/Unit)

Table 79. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2021-2026) & (US$/Unit)

Table 80. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 81. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 82. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2016-2021e) & (USD Million)

Table 83. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2021-2026) & (USD Million)

Table 84. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2021e) & (US$/Unit)

Table 85. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2021-2026) & (US$/Unit)

Table 86. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021e) & (M Units)

Table 87. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units)

Table 88. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021e) & (USD Million)

Table 89. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021-2026) & (USD Million)

Table 90. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 91. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 92. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 93. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 94. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021e) & (M Units)

Table 95. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units)

Table 96. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021e) & (USD Million)

Table 97. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021-2026) & (USD Million)

Table 98. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 99. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 100. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 101. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 102. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021e) & (M Units)

Table 103. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2021-2026) & (M Units)

Table 104. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021e) & (USD Million)

Table 105. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2021-2026) & (USD Million)

Table 106. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 107. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 108. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 109. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 110. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021e) & (M Units)

Table 111. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units)

Table 112. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021e) & (USD Million)

Table 113. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021-2026) & (USD Million)

Table 114. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 115. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 116. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 117. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 118. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021e) & (M Units)

Table 119. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2021-2026) & (M Units)

Table 120. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021e) & (USD Million)

Table 121. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2021-2026) & (USD Million)

Table 122. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021e) & (M Units)

Table 123. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2021-2026) & (M Units)

Table 124. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021e) & (M Units)

Table 125. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2021-2026) & (M Units)

Table 126. Direct Channel Pros & Cons

Table 127. Indirect Channel Pros & Cons

Table 128. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Distributors

Table 129. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Typical Customers

List of Figures

Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Picture

Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2020

Figure 3. 5-HT3 Inhibitors

Figure 4. NK1 Inhibitors

Figure 5. Others

Figure 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2020

Figure 7. Acute CINV

Figure 8. Delayed CINV

Figure 9. Breakthrough CINV

Figure 10. Others

Figure 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, (USD Million) & (M Units): 2020 VS 2021 VS 2026

Figure 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Forecast (2016-2026) & (USD Million)

Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (2016-2026) & (M Units)

Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2026) & (US$/Unit)

Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity (2016-2026) & (M Units)

Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Production Capacity by Geographic Region: 2020 VS 2021

Figure 17. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers

Figure 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints

Figure 19. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends

Figure 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturer in 2020

Figure 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Manufacturer in 2020

Figure 22. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. Top 3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Revenue) Market Share in 2020

Figure 24. Top 6 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturer (Revenue) Market Share in 2020

Figure 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2026)

Figure 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2026)

Figure 27. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026) & (USD Million)

Figure 28. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026) & (USD Million)

Figure 29. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026) & (USD Million)

Figure 30. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026) & (USD Million)

Figure 31. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (2016-2026) & (USD Million)

Figure 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2026)

Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2016-2026)

Figure 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2026) & (US$/Unit)

Figure 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2016-2026)

Figure 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2026) & (US$/Unit)

Figure 38. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2026)

Figure 39. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 40. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2026)

Figure 41. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2026)

Figure 42. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2026)

Figure 46. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 47. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2026)

Figure 48. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2026)

Figure 49. Germany Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2026)

Figure 58. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Korea Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2026)

Figure 65. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 66. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2026)

Figure 67. South America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2026)

Figure 71. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2026)

Figure 72. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2026)

Figure 73. Middle East & Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Egypt Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source